Header Logo

Connection

Kamban Hirasen to Rifampin

This is a "connection" page, showing publications Kamban Hirasen has written about Rifampin.
Connection Strength

0,686
  1. High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa. PLoS One. 2018; 13(10):e0205463.
    View in: PubMed
    Score: 0,563
  2. Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study. PLoS One. 2016; 11(11):e0164974.
    View in: PubMed
    Score: 0,123
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.